Medra, which programs robots with AI to conduct and improve biological experiments, has raised $52 million to build what it says will be one of the largest autonomous labs in the United States. Medra CEO Michelle Lee joins Caroline Hyde and Ed Ludlow on "Bloomberg Tech."
Breakdown
- Medra enables scientists to run experiments via AI-powered robotic arms 8s
- Company shifts lab automation from rigid systems to flexible physical AI 1m 15s
- Medra partners with biopharma firms, including Genentech, for drug discovery 2m 42s
- $52 million funding will expand team, partnerships, and lab automation 3m 15s
- Medra plans to open an autonomous lab with 100 robots next year 3m 24s